<?xml version="1.0" encoding="UTF-8"?>
<p>Acute neurologic syndromes have been reported in both SARS and MERS; this phenomenon seems less common in COVID-19, although the latter pandemic is still evolving. An early report described a SARS patient who developed respiratory failure and status epilepticus several days after mounting a fever; SARS-CoV RNA was detected in her cerebrospinal fluid (CSF), suggesting a demyelinating disease process (Hung 
 <italic>et al</italic>. 
 <xref rid="bib25" ref-type="bibr">2003</xref>). Another case described a pregnant woman who suffered from generalized tonic-clonic seizures on day 22 of a SARS infection; RT-PCR for SARS-CoV in CSF was positive, even though CSF parameters were normal, and no focal neurologic deficits were observed (Lau 
 <italic>et al</italic>. 
 <xref rid="bib31" ref-type="bibr">2004</xref>).
</p>
